These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36510685)

  • 1. Prednisolone pharmacokinetics after oral prednisone administration in paediatric patients with kidney transplant.
    de Truchis C; Bouazza N; Foissac F; Charbit M; Dehoux L; Lui G; Ribot M; Briand N; Zheng Y; Tréluyer JM; Boyer O
    Br J Clin Pharmacol; 2023 May; 89(5):1532-1540. PubMed ID: 36510685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation.
    Bergmann TK; Barraclough KA; Lee KJ; Staatz CE
    Clin Pharmacokinet; 2012 Nov; 51(11):711-41. PubMed ID: 23018468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient characteristics influencing ciclosporin pharmacokinetics and accurate Bayesian estimation of ciclosporin exposure in heart, lung and kidney transplant patients.
    Saint-Marcoux F; Marquet P; Jacqz-Aigrain E; Bernard N; Thiry P; Le Meur Y; Rousseau A
    Clin Pharmacokinet; 2006; 45(9):905-22. PubMed ID: 16928152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipients.
    Falck P; Midtvedt K; Vân Lê TT; Storehagen L; Holdaas H; Hartmann A; Asberg A
    Clin Pharmacokinet; 2009; 48(9):615-23. PubMed ID: 19725595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prednisolone and Prednisone Pharmacokinetics in Pediatric Renal Transplant Recipients-A Prospective Study.
    Skauby RH; Bjerre A; Sæves I; Vethe NT; Bremer S; Svarstad A; Bergan S
    Ther Drug Monit; 2017 Oct; 39(5):472-482. PubMed ID: 28749817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.
    Wilhelm AJ; de Graaf P; Veldkamp AI; Janssen JJ; Huijgens PC; Swart EL
    Br J Clin Pharmacol; 2012 Apr; 73(4):553-63. PubMed ID: 21988410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Explaining variability in ciclosporin exposure in adult kidney transplant recipients.
    Press RR; Ploeger BA; den Hartigh J; van der Straaten T; van Pelt H; Danhof M; de Fijter H; Guchelaar HJ
    Eur J Clin Pharmacol; 2010 Jun; 66(6):579-90. PubMed ID: 20354687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free prednisolone pharmacokinetics predicted from total concentrations in patients with inflammatory - immunonologic conditions.
    Mangin O; Zheng Y; Bouazza N; Foissac F; Benaboud S; Lui G; Hirt D; Mouthon L; Tréluyer JM; Urien S
    Fundam Clin Pharmacol; 2020 Apr; 34(2):270-278. PubMed ID: 31625621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of cyclosporine A in Japanese renal transplant patients: comprehensive analysis in a single center.
    Okada A; Ushigome H; Kanamori M; Morikochi A; Kasai H; Kosaka T; Kokuhu T; Nishimura A; Shibata N; Fukushima K; Yoshimura N; Sugioka N
    Eur J Clin Pharmacol; 2017 Sep; 73(9):1111-1119. PubMed ID: 28620753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of total and unbound prednisone and prednisolone in stable kidney transplant recipients with diabetes mellitus.
    Ionita IA; Ogasawara K; Gohh RY; Akhlaghi F
    Ther Drug Monit; 2014 Aug; 36(4):448-55. PubMed ID: 24452065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of cyclosporine in Korean adults undergoing living-donor kidney transplantation.
    Ji E; Kim MY; Yun HY; Kim KI; Kang W; Kwon KI; Kim IW; Lee HS; Shin WG; Oh JM
    Pharmacotherapy; 2011 Jun; 31(6):574-84. PubMed ID: 21923441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciclosporin population pharmacokinetics and Bayesian estimation in thoracic transplant recipients.
    Fruit D; Rousseau A; Amrein C; Rollé F; Kamar N; Sebbag L; Redonnet M; Epailly E; Marquet P; Prémaud A
    Clin Pharmacokinet; 2013 Apr; 52(4):277-88. PubMed ID: 23400901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental pharmacokinetics of ciclosporin--a population pharmacokinetic study in paediatric renal transplant candidates.
    Fanta S; Jönsson S; Backman JT; Karlsson MO; Hoppu K
    Br J Clin Pharmacol; 2007 Dec; 64(6):772-84. PubMed ID: 17662086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: comparison with similar data from other populations.
    Vadcharavivad S; Praisuwan S; Techawathanawanna N; Treyaprasert W; Avihingsanon Y
    J Clin Pharm Ther; 2016 Jun; 41(3):310-28. PubMed ID: 27191538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prednisone metabolism in recipients of kidney or liver transplants and in lung recipients receiving ketoconazole.
    Jeng S; Chanchairujira T; Jusko W; Steiner R
    Transplantation; 2003 Mar; 75(6):792-5. PubMed ID: 12660503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients.
    Andrews LM; Hesselink DA; van Schaik RHN; van Gelder T; de Fijter JW; Lloberas N; Elens L; Moes DJAR; de Winter BCM
    Br J Clin Pharmacol; 2019 Mar; 85(3):601-615. PubMed ID: 30552703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics and pharmacogenetics of everolimus in renal transplant patients.
    Moes DJ; Press RR; den Hartigh J; van der Straaten T; de Fijter JW; Guchelaar HJ
    Clin Pharmacokinet; 2012 Jul; 51(7):467-80. PubMed ID: 22624503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics of prednisolone and prednisone in adult liver transplant recipients early after transplantation.
    Sæves I; Line PD; Bergan S
    Ther Drug Monit; 2012 Aug; 34(4):452-9. PubMed ID: 22777155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian estimation of mycophenolate mofetil in lung transplantation, using a population pharmacokinetic model developed in kidney and lung transplant recipients.
    de Winter BC; Monchaud C; Prémaud A; Pison C; Kessler R; Reynaud-Gaubert M; Dromer C; Stern M; Guillemain R; Knoop C; Estenne M; Marquet P; Rousseau A
    Clin Pharmacokinet; 2012 Jan; 51(1):29-39. PubMed ID: 22054177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine.
    Kovarik JM; Kahan BD; Kaplan B; Lorber M; Winkler M; Rouilly M; Gerbeau C; Cambon N; Boger R; Rordorf C;
    Clin Pharmacol Ther; 2001 Jan; 69(1):48-56. PubMed ID: 11180038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.